News

Y-mAbs Therapeutics: Engaging at 2024 Global Healthcare Event

Y-mAbs Therapeutics: Engaging at 2024 Global Healthcare Event

Y-mAbs Therapeutics' Conference Participation Announcement

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) is making headlines as it prepares to participate in the much-anticipated Global Healthcare Conference hosted by Citi. This event, known for bringing together leaders in the healthcare sector, offers an invaluable platform for networking and discussing cutting-edge advancements in biopharmaceuticals.

Event Details and Expectations

Scheduled for December, the conference will feature members of the Y-mAbs management team engaging with partners and stakeholders through one-on-one meetings. Such interactions are critical for fostering relationships and aligning on future innovations in cancer treatment.

About Y-mAbs Therapeutics

Y-mAbs Therapeutics is a pioneering biopharmaceutical company dedicated to developing groundbreaking therapies for cancer treatment. The company specializes in radioimmunotherapy and antibody-based products, leveraging innovative technologies to improve patient outcomes.

Innovative Cancer Treatment Solutions

At Y-mAbs, they have introduced the Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform (PRIT). This cutting-edge technology aims to enhance the efficacy of treatments while minimizing side effects for patients undergoing cancer therapies.

The Promise of DANYELZA

The company’s flagship product, DANYELZA (naxitamab-gqgk), is the first FDA-approved treatment specifically designed for patients with relapsed or refractory high-risk neuroblastoma. The significance of DANYELZA cannot be overstated, as it represents a beacon of hope for many families facing the devastating effects of this disease.

Market Impact and Future Prospects

Y-mAbs is poised to make substantial impacts in the oncology market with its innovative approaches. The company's vision emphasizes both the commercialization of existing products and the development of new therapies, positioning itself at the forefront of the biopharmaceutical industry.

Corporate Contact Information

Potential investors and interested parties can direct their inquiries to Courtney Dugan, the VP Head of Investor Relations at Y-mAbs. For any inquiries, you can reach her via email at cdu@ymabs.com.

Frequently Asked Questions

What is Y-mAbs Therapeutics focused on?

Y-mAbs Therapeutics focuses on developing novel treatments for cancer through radioimmunotherapy and antibody products.

When is the 2024 Global Healthcare Conference?

The conference is set for early December. Specific dates include significant opportunities for one-on-one meetings.

What product does Y-mAbs offer for neuroblastoma?

DANYELZA (naxitamab-gqgk) is Y-mAbs' FDA-approved therapy for relapsed neuroblastoma.

How can investors contact Y-mAbs?

Investors can contact Courtney Dugan, the VP of Investor Relations, through email for all inquiries.

What distinguishes Y-mAbs in the biopharmaceutical market?

Y-mAbs is distinguished by its innovative technologies and a commitment to advancing cancer treatment options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Early Dog Guarding Signs Matter Before a Sudden Growl

Updated Category News Views 104

A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...

Continue Reading
Cold Stone’s Holiday Menu Is a Franchisee Traffic Test

Updated Category News Views 56

Peppermint, caramel, and red velvet arrive right when dessert budgets loosen up. Cold Stone Creamery has rolled out a holiday menu running through January 5, 2027, and this is the sort of modest, practical promotion that matters more to a franchise system than the glittery language around it. Nobody should confuse two seasonal ice cream flavors with a corporate...

Continue Reading
JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 104

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
California's AI Oversight Roadmap Raises the Bar Early

Updated Category News Views 41

California has put a real set of teeth on the table, at least on paper. Governor Gavin Newsom's November 18 roadmap for implementing the state's new AI laws embraces an independent verification organization, or IVO, framework that Fathom has been pushing: outside evaluators, licensed by the state, examining whether frontier AI systems create catastrophic risks. For anyone...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 114

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
U.S. Patriot's Veteran Hiring Earns a Real National Nod

Updated Category News Views 58

A workforce award can be cheap wallpaper, but this one has some heft. U.S. Patriot, the veteran-founded and veteran-led military goods retailer owned by GALLS, landed on Military Times’ 2026 Best for Vets: Employers list, placing third in retail and first in Kentucky. The recognition covers 250 organizations, and this is U.S. Patriot’s fourth consecutive appearance....

Continue Reading
Rescue Dog Wines Puts Holiday Bottles to Work for Dogs

Updated Category News Views 66

A Bottle With a Job Beyond the Table Holiday wine promotions usually arrive wrapped in the same tired ribbon: buy more, save a little, pour it at a party, forget it by January. Rescue Dog Wines is taking a more grounded route. The family-owned Lodi-area winery says it gives 50% of profits to animal rescue organizations, and that commitment is not being dressed up as a...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 0

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
Paladone Tests LEGO's Everyday Collectibles Pull Abroad

Updated Category News Views 139

A glowing minifigure lamp is not exactly a macroeconomic event, but licensed merchandise has a funny way of revealing where household spending still has a pulse. Paladone Products has put its first LEGO-branded collection into stores, a modest-looking launch with some real retail logic behind it. This is not a grand toy-box bet on one blockbuster item. It is a spread of...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 229

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US to Showcase Innovations at Capital Markets Day

Updated Category News Views 104

T-Mobile US, Inc. Unveils Plans at Deutsche Telekom Capital Markets Day BELLEVUE, Wash. — T-Mobile US, Inc. (NASDAQ: TMUS) is gearing up to present at the highly anticipated Deutsche Telekom Capital Markets Day, a pivotal event that showcases the company's strategic vision and operational milestones. The presentation will feature insights from Mike Sievert, T-Mobile’s...

Continue Reading
Earnings Insights for Edwards Lifesciences: What to Expect

Updated Category News Views 84

Understanding Edwards Lifesciences's Expected Earnings Release Edwards Lifesciences (NYSE: EW) is gearing up to announce its quarterly earnings, creating a buzz among investors eager for insights on the company's performance. With analysts forecasting an earnings per share (EPS) of $0.65, stakeholders are looking forward to how these results may impact the stock price and...

Continue Reading
Understanding ezPaycheck: A Smart Solution for Restaurant Payroll

Updated Category News Views 139

Introducing ezPaycheck: Tailored Payroll Solution for Restaurants ezPaycheck is designed for restaurant owners who prioritize precision and efficiency in managing payroll. This cutting-edge software allows users to streamline their payroll processes, offering a risk-free trial for up to 30 days to evaluate compatibility with existing systems. Why Choose ezPaycheck for...

Continue Reading
Revolutionizing Pet Compliance with AI: PetScreening Unveils Tool

Updated Category News Views 638

PetScreening Introduces Innovative AI Compliance Tool The solution will help operators capture pet-related revenue that otherwise would have been lost. PetComply.ai Launch Today, PetScreening, a leader in pet policy compliance software, has launched PetComply.ai, an exclusive feature designed to assist property managers in identifying undisclosed pets by renters. This...

Continue Reading
STRATA Skin Sciences Announces Participation in Investor Conference

Updated Category News Views 99

STRATA Skin Sciences Joins the Benchmark Company Investor Conference STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a pioneering medical technology company focused on innovative solutions for dermatologic conditions, has announced participation in the upcoming Benchmark Company 13th Annual Discovery Investor Conference. This event will take place at the New York Athletic...

Continue Reading